{"id":"NCT00905268","sponsor":"Santhera Pharmaceuticals","briefTitle":"A Study of Efficacy, Safety and Tolerability of Idebenone in the Treatment of Friedreich's Ataxia (FRDA) Patients","officialTitle":"A Phase III Double-blind, Randomised, Placebo-controlled Study of the Efficacy, Safety and Tolerability of Idebenone in the Treatment of Friedreich's Ataxia Patients","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-04","primaryCompletion":"2010-01","completion":"2010-01","firstPosted":"2009-05-20","resultsPosted":"2016-06-27","lastUpdate":"2016-06-27"},"enrollment":232,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Friedreich's Ataxia"],"interventions":[{"type":"DRUG","name":"idebenone","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Group A: Idebenone","type":"EXPERIMENTAL"},{"label":"Group B: Idebenone","type":"EXPERIMENTAL"},{"label":"C: Idebenone","type":"EXPERIMENTAL"},{"label":"D: Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this trial is to study the efficacy, safety and tolerability of idebenone in 12 months of treatment in children and adults with Friedreich's Ataxia. This is a randomised placebo-controlled double-blind trial conducted in Europe. Efficacy outcomes include measures of neurological impairment and function, and measures of the heart.","primaryOutcome":{"measure":"Absolute Change in International Cooperative Ataxia Rating Scale (ICARS) Scores From Baseline Assessment to Week 52","timeFrame":"Baseline and week 52","effectByArm":[{"arm":"Group A: Idebenone","deltaMin":1.6,"sd":5.85},{"arm":"Group B: Idebenone","deltaMin":1.7,"sd":6.64},{"arm":"C: Idebenone","deltaMin":1.2,"sd":5.22},{"arm":"D: Placebo","deltaMin":1.1,"sd":6.76}],"pValues":[]},"eligibility":{"minAge":"8 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":4},"locations":{"siteCount":13,"countries":["Austria","Belgium","France","Germany","Netherlands","United Kingdom"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":7,"n":57},"commonTop":["nasopharyngitis","headache","diarrhea","cough","oropharyngeal pain"]}}